COLL: Ascending Triangle detected on 5 Nov 2026

All prices, scores, and news on this page reflect data available before market open on .

Free example: 1 of 45 setups from the 5 Nov 2026 scan. Subscribers get the full list every trading day by 6 AM ET.

On 5 Nov 2026, our scan flagged COLL as a ascending triangle setup scoring 71 out of 98 (Good tier), with a 64% win probability based on our historical pattern database and a 0.53 to 1 risk to reward profile from the published levels. This is a swing trade setup: win probability reflects a multi-day swing hold, not an intraday move. At $23.67, the conservative target is $24.82 with a stop at $21.52.

71 of 98
Good
64%
Moderate
0.53 : 1
$1.15 to target $2.15 to stop
Swing Trading Plan
Entry
$23.67
$24.82
$21.52
2-7 trading days
Exp. Reward
+$0.57
Exp. Risk
-$0.52

Expected figures are probability-weighted from our historical pattern database; Trade R:R is measured from the entry, target and stop levels.

Current Setup
COLL has formed an ascending triangle on the daily chart, a bullish consolidation pattern characterized by declining resistance and static support. Current price stands at $23.67, sandwiched between key support at $23.08 and resistance at $24.31. Structure score of 13.0 indicates solid pattern geometry, while breakout score of 13.0 confirms price is poised at the upper boundary. Volume remains elevated at 803,976 shares (1.3x average), though volume score of 9.82 suggests modest conviction. The 63.64% win probability and 70.82 overall score indicate this is a moderate-quality technical setup forming in an oversold context—stock trades 53.4% below 52-week highs.
Stock Context
Collegium will announce Q3 2026 financial results today (November 5, 2026), before market opens—a critical catalyst coinciding with pattern formation. On August 6, 2026, the company cut 2026 guidance for product revenue from $865-$895 million to $825-$855 million and adjusted EBITDA from $475-$500 million to $445-$470 million, which triggered the 18-month downtrend. However, Collegium reaffirmed full-year 2026 earnings guidance, keeping product revenues net in a range of $805-$825 million at its most recent update. The May 2026 acquisition of AZSTARYS extended the company's long-term revenue outlook with expected patent protection through 2037. The healthcare sector is in a bullish regime (score +0.83), providing tailwind support, though the broader market remains bearish (score -0.31). Today's earnings report will either validate the rebound or spark renewed selling pressure.
What to Expect
A successful breakout above the $24.31 resistance level targets the conservative measured move of $24.82, representing a 4.9% upside from current price. Volume confirmation is essential—breakout conviction requires the 1.3x elevated volume to sustain or increase on the move above resistance, signaling institutional participation. Invalidation occurs if price closes below key support at $23.08, which would negate the ascending triangle structure and likely trigger a breakdown below this double-bottom formation (detected since September 15, pattern quality 28.03). The 63.64% historical win rate suggests roughly 2-in-3 breakout scenarios succeed, though earnings volatility today represents both a catalyst for breakout acceleration and a risk of pattern dissolution.
Risk Factors
Pain franchise decline is staged, with Nucynta facing immediate generic pressure and Belbuca's patent risk centered on an April 2027 trial. The company carries significant execution risk from the AZSTARYS acquisition and integration complexity. RSI at 55.11 is neutral (not overbought), but the stock remains deeply depressed 53.4% below 52-week highs with negative 3-month performance (-18.69%), signaling underlying institutional skepticism. Negative beta of -0.19 suggests COLL moves inverse to market rallies, limiting upside participation if equities accelerate. Most critically, earnings release occurring today introduces binary outcome risk—results that disappoint on ADHD growth (Jornay PM and AZSTARYS) could trigger gap-down reversal that invalidates this entire pattern setup before intraday volume can confirm breakout direction.
How We Find and Score This Setup
We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading. What the terms mean →
Frequently Asked Questions
Is COLL a good swing trade?
COLL scored 71 out of 98 on our ascending triangle scan, with a 64% historical win probability over a 2-7 trading days hold. Good setup based on our systematic scoring.
What is the entry, target, and stop loss for this setup?
The setup's reference price is $23.67, with a conservative target of $24.82 and a stop loss at $21.52.
What would invalidate this ascending triangle setup?
A close below the stop loss at $21.52 would invalidate the setup and suggest the pattern has failed.
How is the win probability calculated?
Win probability is a calibrated estimate of how similar historical ascending triangle setups performed over the following 10 trading days, drawn from a database of 370,000+ historical pattern detections across 6,000+ NYSE and NASDAQ stocks.
Market & Sector Regime
Market
Bearish -0.31
-1.0 0 +1.0
Health Care Sector
Bullish 0.83
-1.0 0 +1.0
Other Patterns Detected Today
Double Bottom
36 days in pattern
Moderate 28.0
Overall Score
36 of 40
Exceptional
Pattern Quality
14 of 20
Good
Setup
11 of 20
Fair
R/R
10 of 18
Fair
Context
Pattern Quality Score
13 of 15
Strong
Structure
13 of 13
Exceptional
Breakout
10 of 12
Strong
Volume
Recent Performance
+1.9%
1W
+3.3%
2W
+8.2%
1M
-18.7%
3M
Momentum & Trend
RSI (14)
55.1
Neutral
MACD Histogram
+0.16
Bullish
Bollinger Band Position
73.8%
Upper Zone
Volatility & Risk
20-Day Volatility
0.29
Moderate
ATR %
3.3%
Medium
Beta
-0.19
Defensive
Volume Analysis
Volume Ratio
1.30x
Above Avg
20-Day Avg Vol
618K
shares / day
Current Volume
804K
shares traded
Price Levels
52W High
$50.79
Target
$24.82
Resistance
$24.31
Current
$23.67
Support
$23.08
Stop Loss
$21.52
52W Low
$21.43
Disclaimer: This analysis is algorithmically generated for educational purposes only and does not constitute financial advice. Past pattern performance does not guarantee future results. Win probabilities are based on historical data across 370,000+ observations. Always conduct your own research and consult a qualified financial advisor. AI-assisted contextual analysis by Claude (Anthropic). Indicators reflect values at time of detection.